Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DURECT Corp (NASDAQ:DRRX)

1.48
Delayed Data
As of Jun 22
 +0.03 / +2.07%
Today’s Change
0.74
Today|||52-Week Range
2.00
+10.45%
Year-to-Date
No recent news for DURECT Corp.

Today’s Trading

Previous close1.45
Today’s open1.45
Day’s range1.41 - 1.49
Volume900,981
Average volume (3 months)751,716
Market cap$205.9M
Dividend yield--
Data as of 06/22/2017

Growth & Valuation

Earnings growth (last year)-36.84%
Earnings growth (this year)+11.54%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-26.66%
P/E ratioNM
Price/Sales12.72
Price/Book24.57

Competitors

 Today’s
change
Today’s
% change
ABUSArbutus Biopharma Co...+0.05+1.35%
STMLStemline Therapeutic...+0.15+1.80%
ABEOAbeona Therapeutics ...+0.60+12.00%
NLNKNewLink Genetics Cor...+0.04+0.54%
Data as of 06/22/2017

Financials

Next reporting dateAugust 7, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$14.0M
Annual profit (last year)-$34.5M
Net profit margin-246.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Scientific Officer
Felix Theeuwes
President, Chief Executive Officer &
Director
James E. Brown
Corporate headquarters
Cupertino, California

Forecasts